ARCHIVES

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991

In Brief: Ovarian Cancer Coalition Opens Office; Winchester Leads Surgical Oncologists

July 11, 1997